Search

everythinglearnresearchcommunity

for

Search:↓

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Enteral supplements can improve symptoms of Cronkhite-Canada syndrome.

IT PEP may help recovery after spinal cord injury, but more research is needed.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Cedrol Nanoemulsion was found to be more effective at promoting hair growth than traditional treatments and had better bioavailability.

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

CaM7 and CNGC14 interaction controls root hair growth in Arabidopsis.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

The protocol allows easy imaging of dividing cells in C. elegans and can be used for other organisms.

The IRE gene is important for normal root hair growth in Arabidopsis plants.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Reticular erythematous mucinosis syndrome can occur with minimal mucin deposition.

HVDRR is caused by VDR gene mutations, leading to vitamin D resistance, treatable with high calcium doses, but alopecia remains permanent.

c-Kit is important for heart regeneration and cancer development.

rPanglaoDB helps study rare cell types by merging RNA data, confirming fibrocytes' role in healing.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Serial Excision Technique improves appearance and quality of life for cicatricial alopecia patients.

17β-estradiol can reduce inflammation in the skin.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

A woman developed a severe skin reaction called toxic epidermal necrolysis after taking the antibiotic cephalexin.